DK432883D0 - Fremgangsmade til fremstilling af n2-glycyl-n-(1-methylen-2-phosphonoethyl)leucinamid (a53868 faktor a) og dermed beslaegtede phosphonopeptid-antibiotika - Google Patents

Fremgangsmade til fremstilling af n2-glycyl-n-(1-methylen-2-phosphonoethyl)leucinamid (a53868 faktor a) og dermed beslaegtede phosphonopeptid-antibiotika

Info

Publication number
DK432883D0
DK432883D0 DK4328/83A DK432883A DK432883D0 DK 432883 D0 DK432883 D0 DK 432883D0 DK 4328/83 A DK4328/83 A DK 4328/83A DK 432883 A DK432883 A DK 432883A DK 432883 D0 DK432883 D0 DK 432883D0
Authority
DK
Denmark
Prior art keywords
phosphonopeptide
leucinamide
phosphonoethyl
glycyl
antibiotics
Prior art date
Application number
DK4328/83A
Other languages
English (en)
Inventor
Ronald Doyle Johnson
Robert Stouffer Gordee
Ralph Emil Kastner
Stephen Hans Larsen
Earl Eugene Ose
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/424,805 external-priority patent/US4463092A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK432883D0 publication Critical patent/DK432883D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3826Acyclic unsaturated acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043Leu-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069Ser-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • C07K5/06095Arg-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1027Tetrapeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK4328/83A 1982-09-27 1983-09-22 Fremgangsmade til fremstilling af n2-glycyl-n-(1-methylen-2-phosphonoethyl)leucinamid (a53868 faktor a) og dermed beslaegtede phosphonopeptid-antibiotika DK432883D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/424,805 US4463092A (en) 1982-09-27 1982-09-27 Process for production antibiotic A53868
US46741983A 1983-02-17 1983-02-17

Publications (1)

Publication Number Publication Date
DK432883D0 true DK432883D0 (da) 1983-09-22

Family

ID=27026459

Family Applications (1)

Application Number Title Priority Date Filing Date
DK4328/83A DK432883D0 (da) 1982-09-27 1983-09-22 Fremgangsmade til fremstilling af n2-glycyl-n-(1-methylen-2-phosphonoethyl)leucinamid (a53868 faktor a) og dermed beslaegtede phosphonopeptid-antibiotika

Country Status (8)

Country Link
EP (1) EP0107907A3 (da)
DD (1) DD210307A5 (da)
DK (1) DK432883D0 (da)
ES (1) ES8504253A1 (da)
FI (1) FI833455A7 (da)
GB (1) GB2127413A (da)
PL (1) PL243917A1 (da)
PT (1) PT77368A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215805A1 (en) * 1985-01-18 1987-04-01 MERCK PATENT GmbH Immunoregulatory peptides
WO2020010587A1 (zh) 2018-07-12 2020-01-16 苏州大学张家港工业技术研究院 β-膦酰基烯胺衍生物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48835A (en) * 1975-01-27 1979-05-31 Sparamedica Ag Amino acyl and peptidyl derivatives of phophonic acids, their preparation and pharmaceutical compositions containingthem
US4206156A (en) * 1976-07-27 1980-06-03 Fujisawa Pharmaceutical Company, Limited Hydroxyaminohydrocarbonphosphonic acids
CA1108125A (en) * 1977-12-23 1981-09-01 Frank R. Atherton Olgiopeptide derivatives of phosphonic acid
US4331591A (en) * 1978-10-05 1982-05-25 Ciba-Geigy Corporation Chemical process for the production of α-aminophosphonic acids and peptide derivatives

Also Published As

Publication number Publication date
EP0107907A2 (en) 1984-05-09
PL243917A1 (en) 1984-08-13
FI833455A0 (fi) 1983-09-26
PT77368A (en) 1983-10-01
ES525961A0 (es) 1985-04-16
DD210307A5 (de) 1984-06-06
FI833455L (fi) 1984-03-28
ES8504253A1 (es) 1985-04-16
GB8325361D0 (en) 1983-10-26
EP0107907A3 (en) 1985-11-27
GB2127413A (en) 1984-04-11
FI833455A7 (fi) 1984-03-28

Similar Documents

Publication Publication Date Title
DK318583D0 (da) N-(bicyklisk heterocyklyl)-4-piperidinaminer og fremgangsmader til fremstilling deraf
DK410483A (da) Vaevsprotese og fremgangsmaade til fremstilling af samme
DK276683A (da) Carbapenemer og fremgangsmaade til fremstilling deraf
DK107586A (da) Transducer og fremgangsmaade til fremstilling af en saadan
DK531983D0 (da) Karprotese og fremgangsmade til fremstilling af en karprotese
DK409183D0 (da) Fremgangsmade til fremstilling af et farmaceutisk praeparat indeholdende et eller flere betalaktam-antibiotika
DK158682A (da) Fremgangsmaade til fremstilling af azopigmentpraeparater og disses anvendelse
DK28883D0 (da) Dentalkonstruktion og fremgangsmade til fremstilling af samme
AU558319B2 (en) N-(2-methoxyethyl)-noroxymorphone
NO833438L (no) Kalandrert plate av myrtorv og fremgangsmaate for fremstilling derav
DK343183A (da) Ketoquinoliner og fremgangsmaade til fremstilling deraf
DK129983D0 (da) 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser og fremgangsmader til fremstilling deraf
DK432883D0 (da) Fremgangsmade til fremstilling af n2-glycyl-n-(1-methylen-2-phosphonoethyl)leucinamid (a53868 faktor a) og dermed beslaegtede phosphonopeptid-antibiotika
DK607683D0 (da) Human endogen cancer-regulerende faktor og fremgangsmade til fremstilling af en sadan faktor
DK536584A (da) Antibiotikum benaevnt a 39079 faktor s-1 og fremgangsmaade til fremstilling heraf
DK81192D0 (da) Substituerede ethandiimidamider og fremgangsmaade til fremstilling deraf
DK440281A (da) Fremgangsmaade til fremstilling af n-carboxylalkyldipeptider og derivater deraf
DK403183D0 (da) Impraegneringsmiddel for broed og fremgangsmade til fremstilling af samme
NO830416L (no) Peptidergotalkaloider og fremgangsmaaten for deres fremstilling
DK411582A (da) Antibiotika benaevnt a-32724 og fremgangsmaade til fremstilling deraf
DK162475C (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin og fremgangsmaade til fremstiling af praeparatet
DK435283A (da) Diastereomerer og fremgangsmaade til fremstilling deraf
DK104783A (da) Fremgangsmaade til fremstilling af antibiotika
DK84183A (da) Benzyletherderivater af pentiter og fremgangsmaade til fremstilling deraf
DK153179C (da) Fjernvarmeledning og fremgangsmaade til fremstilling af en saadan

Legal Events

Date Code Title Description
ATS Application withdrawn